Results 61 to 70 of about 22,435 (217)

Besifloxacin ophthalmic suspension, 0.6%: a novel topical fluoroquinolone for bacterial conjunctivitis [PDF]

open access: yes, 2012
Acute bacterial conjunctivitis, the most common cause of conjunctivitis, is responsible for approximately 1% of all primary-care consultations. Of the topical ophthalmic antibiotics used to treat acute bacterial conjunctivitis, fluoroquinolones are ...
O'Brien, Terrence P
core   +1 more source

Effects of Live and Heat‐Treated Bifidobacterium longum CECT 7347 in Adults With Allergic Rhinitis: A Randomised, Double‐Blind, Placebo‐Controlled Trial

open access: yesAllergy, EarlyView.
This randomized, double‐blind, placebo‐controlled trial evaluated the effects of live probiotic and HT postbiotic B. longum CECT 7347 in adults with moderate–severe allergic rhinitis. Postbiotic supplementation for 8 weeks significantly reduced CSMS and dSS, exceeding the established CSMS MCID with a 33% greater improvement, when compared to placebo ...
Ana Cardoso   +9 more
wiley   +1 more source

Kinetics of kill of bacterial conjunctivitis isolates with moxifloxacin, a fluoroquinolone, compared with the aminoglycosides tobramycin and gentamicin [PDF]

open access: yes, 2010
Rudolph S Wagner1, David B Granet2, Steven J Lichtenstein3, Tiffany Jamison4, Joseph J Dajcs4, Robert D Gross5, Paul Cockrum41New Jersey Medical School, Newark, NJ, USA; 2Ratner Children’s Eye Center, University of California – San ...
Steven J Lichtenstein   +3 more
core  

Bacterial conjunctivitis: clinical features, types and complications; a systematic review [PDF]

open access: yes
Bacterial conjunctivitis is an eye illness with inflammatory conjunctiva conditions. Neonatorum conjunctivitis was first discovered in 1750 by Quellmaz. In this article, an effective systematic study intends to provide an overview of etiology, prevalence,
Areesha Naveed   +9 more
core   +2 more sources

Antibiotics versus placebo for acute bacterial conjunctivitis [PDF]

open access: yes, 2012
BACKGROUND: There are concerns about whether antibiotic therapy confers significant clinical benefit in the treatment of acute bacterial conjunctivitis. OBJECTIVES: The aim of this review was to assess the benefit and harm of antibiotic therapy in the
McLean, Susannah   +5 more
core   +1 more source

Efficacy of Fluoroquinolones on Methicillin-Resistant Staphylococcus aureus Strains Isolated from External Ocular Infections [PDF]

open access: yesمجله دانشگاه علوم پزشکی گرگان, 2023
Background and Objective: Staphylococcus aureus is one of the most common causes of bacterial keratitis and conjunctivitis. This study was done to determine the efficacy of fluoroquinolones on Methicillin-resistant Staphylococcus aureus (MRSA) strains ...
Mehri Hosseini   +2 more
doaj  

Type‐2‐Inflammatory‐Diseases Share Comorbidities, Molecular Signatures, IL4/IL13 Genetics, and Response to IL4/IL13 Blockade

open access: yesAllergy, EarlyView.
Studies suggest that type 2 inflammatory diseases are driven by overactivation of the IL4/IL13 pathway, manifesting differently in distinct tissues. We performed quantitative analyses using several large independent datasets to explore the interrelation of type 2 inflammatory diseases based on co‐prevalence, genetic predispositions, and transcriptomic ...
Jennifer D. Hamilton   +19 more
wiley   +1 more source

Peripheral ulcerative keratitis triggered by bacterial conjunctivitis [PDF]

open access: yes, 1970
Background: Peripheral ulcerative keratitis (PUK) is a disorder consisting of a crescent-shaped destructive inflammation of the perilimbal corneal stroma.
A Pokharel, M Bajracharya, S Subedi
core   +1 more source

Dexamethasone Improves Ofloxacin Efficacy in Treating Acute Bacterial Conjunctivitis: Evidence from A Rabbit Model [PDF]

open access: yes, 2020
Background: Bacterial conjunctivitis represents the major part of infectious conjunctivitis and, although it generally shows a spontaneous resolution, antibiotics speed the elimination of bacteria from the conjunctiva thus limiting the duration of the
Noemi Poma   +3 more
core   +1 more source

Diet–Microbiome–Immune Interactions at the Gut Mucosa in Food Allergy: Mechanisms, Gaps, and Therapeutic Implications

open access: yesAllergy, EarlyView.
ABSTRACT Mucosal surfaces are sites of highly dynamic interactions among epithelial and immune cells, environmental exposures, particularly dietary inputs, and the diverse microbial communities and their metabolites. These elements continually influence each other to maintain homeostasis and ensure appropriate immune discrimination between pathogens ...
Clara Delaroque   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy